Cancer genomics

Primary tabs

This project aims at supporting and enhancing modern oncology, by implementing a cultural, technological and legal integrated framework (EUCANCan) across Europe and Canada, for the efficient analysis, management and sharing of cancer genomic data. This cooperative framework is not only expected to immediately contribute to improve biomedical research in cancer, but to also...

We propose to create the EUropean-CANadian Cancer network (EUCANCan), a federated infrastructure whose mission is to enable Personalized Medicine in Oncology by promoting the generation and sharing of harmonized genomic and phenotypic data. EUCANCan builds on work performed by members of the consortium and related projects to align and interconnect existing European and...

Un dels grans reptes de la indústria farmacèutica és la medicina personalitzada. Difícilment una sola molècula esdevindrà un tractament farmacològic amb èxit per a tota la població mundial donada la gran variabilitat genètica natural en la població. Actualment l’elevat índex de...

Chronic Lymphocytic Leukemia (CLL) is one of the most frequent tumors in Western countries. CLL represents 35% of all leukemias with an incidence of 3-7 per 100.000 habitants and reaches 12-15/100.000 in people over 60 years. The disease is heterogeneous; there are patients who have a long clinical evolution with a stable disease whereas others follow a progressive course...

Pages